Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07LYC
|
|||
| Former ID |
DIB014268
|
|||
| Drug Name |
SCYX-7158
|
|||
| Synonyms |
AN-2920; AN-3520; AN-5568; SCYX-6759; Trypanocidal compounds (human African trypanosomiasis); Oxaborole series (human African trypanosomiasis), SCYNEXIS/DNDi/Pace University/Anacor Pharmaceuticals; Trypanocidal compounds (human African trypanosomiasis), SCYNEXIS/DNDi/Pace University/Anacor Pharmaceuticals
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Trypanosomiasis [ICD-11: 1D51-1F53; ICD-10: B56-B57; ICD-9: 086.5-086] | Phase 1 | [1] | |
| Company |
SCYNEXIS Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H14BF4NO3
|
|||
| Canonical SMILES |
B1(C2=C(C=CC(=C2)NC(=O)C3=C(C=C(C=C3)F)C(F)(F)F)C(O1)(C)C)O
|
|||
| InChI |
1S/C17H14BF4NO3/c1-16(2)12-6-4-10(8-14(12)18(25)26-16)23-15(24)11-5-3-9(19)7-13(11)17(20,21)22/h3-8,25H,1-2H3,(H,23,24)
|
|||
| InChIKey |
PTYGDEXEGLDNAZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1266084-51-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01533961) Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.